A sequential CRISPR approach to rationally design robust combination treatments in pancreatic cancer

| Funding period: 2021 - 2023

Active

University of Melbourne Researchers

Frederic Hollande Clinical Pathology

Kaylene Simpson Biochemistry and Pharmacology

Tracy Putoczki Medical Biology (w.e.h.i.)

Belinda Lee Medical Biology (w.e.h.i.)